On November 4, 2025, Evoke announced that it has entered into an agreement and plan of merger (the "Merger Agreement”) with ...
TORONTO, Nov. 12, 2025 /CNW/ - Dye & Durham Limited (the "Company" or "Dye & Durham") (TSX: DND) today announced preliminary ...
Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of ...
11h
CT’s Pfizer acquires obesity drug start-up. A ‘strategic milestone,’ pharmaceutical giant CEO said
Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...
Evernorth Holdings Inc. ("Evernorth"), a newly formed Nevada corporation that will enable XRP adoption on an institutional ...
Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”) is researching the security requirements and next steps for a full cultivation ...
Pedro Resources Ltd. (CSE: VBN) (“Pedro” or the “Company”) announces that it has issued a promissory note (the “Bridge Note”) to a ...
Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...
Net cash used in investing activities increased from $ (0.2 million) for the nine months ended September 30, 2024 to $ (65.6 million) for the nine months ended September 30, 2025, primarily as a ...
Conference call will be held today, Thursday, November 13 at 10:00 am ET Woburn, MA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company speci ...
Q3 2025 Earnings Call November 13, 2025 8:00 AM ESTCompany ParticipantsRajiv Kanishka De Silva - CEO & DirectorDomenic Penna ...
Thank you, operator. Good morning, everyone, and welcome to Team, Inc.'s discussion of our third quarter 2025 operational and financial results. On the discussion today is Keith Tucker, our Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback